A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

Abstract Background Patients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. However, no consensus has been reached regarding which genetic variants si...

Full description

Bibliographic Details
Main Authors: Caroul Chawar, Alannah Hillmer, Stephanie Sanger, Alessia D’Elia, Balpreet Panesar, Lucy Guan, Dave Xiaofei Xie, Nandini Bansal, Aamna Abdullah, Flavio Kapczinski, Guillaume Pare, Lehana Thabane, Zainab Samaan
Format: Article
Language:English
Published: BMC 2021-11-01
Series:Addiction Science & Clinical Practice
Subjects:
Opioid
Pharmacogenetic
MOUD
Methadone
GWAS
Systematic review
Online Access:https://doi.org/10.1186/s13722-021-00278-y

Internet

https://doi.org/10.1186/s13722-021-00278-y

Similar Items